DNMT3A was also overexpressed in many human cancers such as pituitary adenoma, acute myeloid leukemia, and vulvar squamous cell carcinoma and led to the silencing of tumor suppressors such as p16 and RASSF1A [21]. This evidence concerns the gene CDKN2A and cancer.